National Louis University Selects BIO-key’s PortalGuard� Identity and Access Platform to Improve the Digital Experience for Users and Enhance Cybersecurity Insurance Compliance

WALL, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that the National Louis University (NLU) has selected its PortalGuard IDaaS^� platform. BIO-key’s solution will improve access security to applications, enhance the user experience, and achieve cybersecurity insurance compliance for National Louis, including its primary Chicago and Tampa campuses, with remote access nationwide.

NLU sought to replace its legacy solution and provide students, faculty, and administrators with more secure and frictionless access to institutional data and applications like Office 365, Ellucian Banner and Degree Works, the D2L online learning platform, Zoom, and ServiceNow. A key objective was to provide end-users with flexible multi-factor authentication options as an effective countermeasure against cybercriminals and unauthorized access to accounts. Ultimately, NLU chose to implement PortalGuard IDaaS not only to leverage its enhanced security features but also for the cloud platform’s scalability, redundancy, and cost competitiveness.

“Many higher education institutions are pursuing IAM initiatives for this type of cybersecurity improvement, and we are ready to help other institutions achieve these same objectives,” said Mark Cochran, President of BIO-key – PortalGuard. “It has become increasingly clear that higher education is particularly vulnerable to a range of potentially crippling cyberattacks, driving the requirement for proven IAM solutions that enable secure and convenient access to campus-wide systems and data. PortalGuard IDaaS delivers convenience and affordability over competitive solutions with the comfort provided by an enterprise-grade cloud security platform.”

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

BIO-key Media Contact:
Erin Knapp
Matter Communications
BIO-key@matternow.com
914-260-3158

Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800